166 related articles for article (PubMed ID: 3535927)
1. Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid cell-specific monoclonal antibodies.
Ball ED; Mills LE; Coughlin CT; Beck JR; Cornwell GG
Blood; 1986 Dec; 68(6):1311-5. PubMed ID: 3535927
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies to carbohydrate antigens in autologous bone marrow transplantation.
Ball ED; Howell AL
J Cell Biochem; 1988 Apr; 36(4):445-52. PubMed ID: 3288649
[TBL] [Abstract][Full Text] [Related]
3. Autologous bone marrow transplantation for acute myeloid leukemia using monoclonal antibody-purged bone marrow.
Ball ED; Mills LE; Cornwell GG; Davis BH; Coughlin CT; Howell AL; Stukel TA; Dain BJ; McMillan R; Spruce W
Blood; 1990 Mar; 75(5):1199-206. PubMed ID: 2306522
[TBL] [Abstract][Full Text] [Related]
4. Effects of anti-myeloid antibodies on the generation of hematopoietic colony-forming units in long-term bone marrow culture.
Ball ED; Keefe KA; McDermott JM
Bone Marrow Transplant; 1989 May; 4(3):309-15. PubMed ID: 2659116
[TBL] [Abstract][Full Text] [Related]
5. Improved outcome for high-risk acute myeloid leukemia patients using autologous bone marrow transplantation and monoclonal antibody-purged bone marrow.
Selvaggi KJ; Wilson JW; Mills LE; Cornwell GG; Hurd D; Dodge W; Gingrich R; Martin SE; McMillan R; Miller W
Blood; 1994 Mar; 83(6):1698-705. PubMed ID: 8123862
[TBL] [Abstract][Full Text] [Related]
6. Preliminary clinical trial of autologous bone marrow transplantation after in vitro monoclonal antibody and complement treatments in null cell-type acute lymphocytic leukemia.
Morishima Y; Sao H; Ueda R; Morishita Y; Murase T; Kodera Y; Ohno R; Tahara T; Yoshikawa S; Kato Y
Jpn J Cancer Res; 1985 Dec; 76(12):1222-9. PubMed ID: 3937834
[TBL] [Abstract][Full Text] [Related]
7. Pre-clinical evaluation of anti-lacto-N-fucopentaose III (CD15) monoclonal antibodies for ex vivo bone marrow purging in acute myeloid leukemia.
Guyotat D; Shi ZH; Campos L; Rabat M; Bonnier S; Poncelet P; Laurent JC; Fiere D
Bone Marrow Transplant; 1990 Dec; 6(6):385-90. PubMed ID: 1982926
[TBL] [Abstract][Full Text] [Related]
8. Human bone marrow depleted of CD33-positive cells mediates delayed but durable reconstitution of hematopoiesis: clinical trial of MY9 monoclonal antibody-purged autografts for the treatment of acute myeloid leukemia.
Robertson MJ; Soiffer RJ; Freedman AS; Rabinowe SL; Anderson KC; Ervin TJ; Murray C; Dear K; Griffin JD; Nadler LM
Blood; 1992 May; 79(9):2229-36. PubMed ID: 1571539
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia.
Wisniewski D; Strife A; Arlin Z; Knowles R; Lambek C; Gulati S; McHendry B; McKenzie S; Clarkson B
Leukemia; 1989 Jun; 3(6):446-52. PubMed ID: 2657231
[TBL] [Abstract][Full Text] [Related]
10. Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination.
Lemoli RM; Gasparetto C; Scheinberg DA; Moore MA; Clarkson BD; Gulati SC
Blood; 1991 Apr; 77(8):1829-36. PubMed ID: 2015406
[TBL] [Abstract][Full Text] [Related]
11. Autologous bone marrow transplantation in acute myeloid leukemia after in-vitro purging with an anti-lacto-N-fucopentaose III antibody and rabbit complement.
Ferrero D; De Fabritiis P; Amadori S; De Felice L; Gallo E; Meloni G; Pregno P; Pulsoni A; Simone F; Tarella C
Leuk Res; 1987; 11(3):265-72. PubMed ID: 3550300
[TBL] [Abstract][Full Text] [Related]
12. Serological study for in vitro use of monoclonal antibody for autologous bone marrow transplantation in null cell-type acute lymphocytic leukemia.
Sao H; Morishima Y; Ueda R; Yoshikawa S; Kodera Y; Ohno R; Takahashi T
Jpn J Cancer Res; 1985 Dec; 76(12):1212-21. PubMed ID: 3937833
[TBL] [Abstract][Full Text] [Related]
13. Autologous bone marrow transplantation for acute myeloid leukemia following in vitro treatment with neuraminidase and monoclonal antibodies.
Ball ED; Vredenburgh JJ; Mills LE; Cornwell GG; Schwarz L; Howell AL; Troy K
Bone Marrow Transplant; 1990 Oct; 6(4):277-80. PubMed ID: 1982228
[TBL] [Abstract][Full Text] [Related]
14. Leukemia diagnosis and testing of complement-fixing antibodies for bone marrow purging in acute lymphoid leukemia.
Campana D; Janossy G
Blood; 1986 Dec; 68(6):1264-71. PubMed ID: 3535926
[TBL] [Abstract][Full Text] [Related]
15. Engraftment of leukocyte subsets following autologous bone marrow transplantation in acute myeloid leukemia using anti-myeloid (CD14 and CD15) monoclonal antibody-purged bone marrow.
Ericson SG; Colby E; Welch L; Ball ED
Bone Marrow Transplant; 1992 Feb; 9(2):129-37. PubMed ID: 1373982
[TBL] [Abstract][Full Text] [Related]
16. Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purging.
Uckun FM; Kersey JH; Haake R; Weisdorf D; Ramsay NK
Blood; 1992 Feb; 79(4):1094-104. PubMed ID: 1531306
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies to myeloid differentiation antigens: in vivo studies of three patients with acute myelogenous leukemia.
Ball ED; Bernier GM; Cornwell GG; McIntyre OR; O'Donnell JF; Fanger MW
Blood; 1983 Dec; 62(6):1203-10. PubMed ID: 6605773
[TBL] [Abstract][Full Text] [Related]
18. Continuous infusion of complement by an automated cell processor enhances cytotoxicity of monoclonal antibody sensitized leukemia cells.
Howell AL; Fogg-Leach M; Davis BH; Ball ED
Bone Marrow Transplant; 1989 May; 4(3):317-22. PubMed ID: 2659117
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody-mediated cytotoxicity of human myeloid leukemia cells: an in vitro model for estimating efficiency and optimal conditions for cytolysis.
Howell AL; Ball ED
Blood; 1985 Sep; 66(3):649-54. PubMed ID: 3861203
[TBL] [Abstract][Full Text] [Related]
20. Autologous bone-marrow transplantation in CALLA-positive acute lymphoblastic leukemia after in-vitro treatment with J5 monoclonal antibody and complement.
Ritz J; Sallan SE; Bast RC; Lipton JM; Clavell LA; Feeney M; Hercend T; Nathan DG; Schlossman SF
Lancet; 1982 Jul; 2(8289):60-3. PubMed ID: 6177990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
